Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model

Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats

(2019) Yong Li et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Clostridium butyricum regulates visceral hypersensitivity of irritable bowel syndrome by inhibiting colonic mucous low grade inflammation through its action on NLRP6

(2018) Kejia Zhao et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Electroacupuncture Relieves Visceral Hypersensitivity by Inactivating Protease-Activated Receptor 2 in a Rat Model of Postinfectious Irritable Bowel Syndrome

(2018) Wanli Xu et al.   Evidence-based Complementary and Alternative Medicine

Regulation of the gut microbiome by inflammasomes

(2017) Grace Y. Chen   FREE RADICAL BIOLOGY AND MEDICINE

Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link

(2017) Uday C. Ghoshal et al.   Nature Reviews Gastroenterology & Hepatology

Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood

(2017) NurFadhilah Yusof et al.   Gut Pathogens

Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients

(2016) Xiao-Yan Zhou   WORLD JOURNAL OF GASTROENTEROLOGY

Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease

(2016) Toshihiko Tomita et al.   Journal of Neurogastroenterology and Motility

Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling

(2015) Maayan Levy et al.   CELL

Proteobacteria: microbial signature of dysbiosis in gut microbiota

(2015) Na-Ri Shin et al.   TRENDS IN BIOTECHNOLOGY

Role of NLRP3 inflammasome inBifidobacterium longum-regulated visceral hypersensitivity of postinfectious irritable bowel syndrome

(2015) Qiao-Yan Gu et al.   Artificial Cells Nanomedicine and Biotechnology

Fusobacterium Detected in Colonic Biopsy and Clinicopathological Features of Ulcerative Colitis in Japan

(2014) Tomomitsu Tahara et al.   DIGESTIVE DISEASES AND SCIENCES

The microbial basis of inflammatory bowel diseases

(2014) Sushila R. Dalal et al.   JOURNAL OF CLINICAL INVESTIGATION

Crosstalk at the mucosal border: importance of the gut microenvironment in IBS

(2014) Lena Öhman et al.   Nature Reviews Gastroenterology & Hepatology

Irritable bowel syndrome: A microbiome-gut-brain axis disorder?

(2014) Paul J Kennedy   WORLD JOURNAL OF GASTROENTEROLOGY

Interleukin-18, more than a Th1 cytokine

(2013) Daniela Novick et al.   SEMINARS IN IMMUNOLOGY

Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats

(2012) Hong-Yan Qin   WORLD JOURNAL OF GASTROENTEROLOGY

Investigating the biological and clinical significance of human dysbioses

(2011) Daniel N. Frank et al.   TRENDS IN MICROBIOLOGY

Bactericidal Activity of Mouse α-Defensin Cryptdin-4 Predominantly Affects Noncommensal Bacteria

(2010) Koji Masuda et al.   Journal of Innate Immunity

Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum

(2009) A. Swidsinski et al.   GUT